Betahistine is typically taken for several months, not just a few weeks. Most prescribers recommend an initial course of at least two to three months before judging whether it’s working, and treatment courses of up to 12 months are common for conditions like Ménière’s disease. The exact duration depends on the type of vertigo you have, how well you respond, and whether symptoms return after stopping.
What to Expect in the First Few Weeks
Betahistine doesn’t work immediately. It generally takes a couple of weeks before you notice any improvement in your symptoms, according to the NHS. This is because the medication works by gradually improving blood flow in the inner ear and adjusting how your brain processes balance signals. It boosts activity in the parts of your nervous system that use histamine, a chemical messenger involved in balance regulation.
Because of this slow onset, it’s important not to judge the medication too early. Stopping after a few days because you don’t feel better would be premature. If you’ve been taking it for three to four weeks with no change at all, that’s a reasonable point to check in with whoever prescribed it.
Typical Treatment Duration
For Ménière’s disease, which is the primary condition betahistine is prescribed for, treatment courses often run for 6 to 12 months. A major clinical trial published in The BMJ used a nine-month treatment period, which researchers considered necessary to properly assess the drug’s ability to prevent vertigo attacks over time. Clinical experience has pointed toward long-term treatment of up to 12 months as the standard approach.
The goal with betahistine isn’t to stop a vertigo attack in progress. It’s a preventive medication, taken daily to reduce how often attacks happen and how severe they are. Think of it more like a maintenance treatment than a rescue medication. This is why the treatment window is measured in months rather than days.
Once your symptoms are well controlled, your prescriber may lower the dose rather than stopping it outright. The usual starting dose is 16 mg taken three times a day, and this can be reduced to 8 mg three times a day once things stabilize. The maximum recommended daily dose is 48 mg.
When Treatment Might Be Shorter or Longer
Not all vertigo is the same, and betahistine isn’t equally useful for every type. It’s primarily prescribed for Ménière’s disease, a condition caused by fluid buildup in the inner ear that produces episodes of spinning vertigo along with hearing loss, tinnitus, and a feeling of fullness in the ear. For this condition, longer courses make sense because Ménière’s is a chronic, recurring problem.
If you have benign paroxysmal positional vertigo (BPPV), which is the most common type of vertigo and is caused by tiny crystals dislodging inside your ear canal, betahistine is not the standard treatment. BPPV is typically treated with specific head-positioning maneuvers that physically move the crystals back into place. If you’ve been prescribed betahistine for vertigo that hasn’t been clearly diagnosed, it’s worth clarifying with your doctor what type of vertigo you have, because the treatment approach differs significantly.
Some people stay on betahistine for years if they have frequent Ménière’s attacks that return whenever they stop. Others find that after 6 to 12 months, their symptoms have settled enough that they can taper off. There’s no single correct answer. The duration is guided by your individual response.
How to Know If It’s Working
The main signs that betahistine is doing its job are fewer vertigo episodes, shorter episodes when they do occur, and less severe spinning. You may also notice improvements in tinnitus or the pressure sensation in your ear, though these benefits vary from person to person.
Keep a rough mental note (or written log) of how often you’re having vertigo episodes and how intense they are. This gives you and your prescriber something concrete to work with when deciding whether to continue, adjust the dose, or stop. If you’ve been on the medication for two to three months at the full dose with no noticeable change in the frequency or severity of your attacks, that’s a reasonable point to reassess whether betahistine is the right approach for you.
What Happens When You Stop
Betahistine doesn’t cure the underlying condition. It manages symptoms while you take it. For some people with Ménière’s disease, the condition naturally becomes less active over time, and stopping betahistine after a long course works out fine. For others, symptoms return within weeks or months of stopping, and they need to restart.
There’s no dangerous withdrawal effect from stopping betahistine, but most prescribers prefer a gradual dose reduction rather than stopping abruptly. This makes it easier to tell whether your symptoms are truly under control on their own or whether they come back without the medication’s support.
Availability Varies by Country
Betahistine is widely prescribed in the UK, Europe, Canada, and many other countries. In the United States, it is not FDA-approved. It was briefly approved in the 1960s, but approval was withdrawn in 1971 due to what regulators considered insufficient evidence of effectiveness at the time. If you’re in the US, your doctor may suggest alternative treatments for Ménière’s disease, or in some cases betahistine can be obtained through compounding pharmacies.